Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
472857010 | Co-flumactone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
727203010 | Co-flumactone (substance) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
1194881018 | Co-flumactone (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT core module |
2572079017 | Hydroflumethiazide + spironolactone (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
2576053011 | Hydroflumethiazide + spironolactone | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3485074019 | Product containing hydroflumethiazide and spironolactone (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3493571017 | Product containing hydroflumethiazide and spironolactone | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3666640014 | Hydroflumethiazide and spironolactone product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3715206010 | Hydroflumethiazide- and spironolactone-containing product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
102484601000001117 | Co-flumactone | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet | Is a | False | Product containing hydroflumethiazide and spironolactone | Inferred relationship | Existential restriction modifier | |
Product containing precisely hydroflumethiazide 50 milligram and spironolactone 50 milligram/1 each conventional release oral tablet | Is a | False | Product containing hydroflumethiazide and spironolactone | Inferred relationship | Existential restriction modifier | |
Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) | Is a | True | Product containing hydroflumethiazide and spironolactone | Inferred relationship | Existential restriction modifier | |
Co-flumactone | Is a | True | Product containing hydroflumethiazide and spironolactone | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets